Back
Ionis Pharmaceuticals 10K Form
Sell
39
IONS
Ionis Pharmaceuticals
Last Price:
38.76
Seasonality Move:
10.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2023-05-03 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2022-11-09 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2022-05-04 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
Receive IONS News And Ratings
See the #1 stock for the next 7 days that we like better than IONS
IONS Financial Statistics
Sales & Book Value
| Annual Sales: | $787.65M |
|---|---|
| Cash Flow: | $-140.14M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.81 |
| Price / Book: | 23.21 |
Profitability
| EPS (TTM): | -2.52000 |
|---|---|
| Net Income (TTM): | $-365.74M |
| Gross Margin: | $778.51M |
| Return on Equity: | -108.17% |
| Return on Assets: | -12.74% |
Ionis Pharmaceuticals Earnings Forecast
Key Ionis Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 34 years for IONS is 98.84%.
- The Selling, General & Administrative Expenses for IONS have been equal to 29.53% of Gross Profit Margin.
- The Research & Development expenses have been 114.22% of Revenue.
- The Interest Expense is -20.64% of Operating Income.
- The Net Earning history of IONS is -46.50% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 16 years.
Ionis Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IONS |
| CUSIP: | 462222 |
| Website: | ionispharma.com |
Debt
| Debt-to-Equity Ratio: | 4.84 |
|---|---|
| Current Ratio: | 7.61 |
| Quick Ratio: | 6.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IONS Technical Analysis vs Fundamental Analysis
Sell
39
Ionis Pharmaceuticals (IONS)
is a Sell
Is Ionis Pharmaceuticals a Buy or a Sell?
-
Ionis Pharmaceuticals stock is rated a Sell
The current Ionis Pharmaceuticals [IONS] share price is $38.80. The Score for IONS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.